HOME >> BIOLOGY >> NEWS
Dramatic results from combo therapy surprises Krabb-disease researchers

Jan. 9, 2007 -- By all expectations, it shouldn't have worked as well as it did. A combination of bone marrow transplantation and gene therapy greatly lengthened the lives of laboratory mice doomed by a rapidly progressing, fatal neurodegenerative disorder also found in people.

The Washington University School of Medicine in St. Louis researchers who made the discovery set out with low hopes for the combination therapy because on its own, each treatment was only modestly effective for the sick mice.

The mice are called Twitcher mice because the damage that happens in their nervous systems results in twitching. In people, the same genetic defect causes Krabb disease, or globoid-cell leukodystrophy, an inherited disorder that destroys both the brain and the nerves of the body.

"We had everything we needed to test the combination treatment, so we said, 'Let's just give it a try,'" says the study's senior author, Mark Sands, Ph.D., associate professor of medicine and of genetics. "Alone, these therapies resulted in a small survival benefit, but with the combination we were seeing mice with dramatically extended life spans. Ninety-five percent of the Twitcher mice that had the combination treatment were still alive after all the other Twitcher mice had died."

The researchers gave newborn Twitcher mice injections of a gene therapy vector into the brain and infused them with bone marrow from healthy mice. Mice receiving the dual therapy lived more than twice as long (greater than 100 days), on average, as untreated mice or those given a single therapy and had improved motor skills. The research is reported in the January issue of Molecular Therapy.

Although not considered a cure at this stage, the combination therapy offers hope for treatment of diseases like Krabb, which are termed lysosomal storage diseases. These disorders include Niemann-Pick and Tay-Sachs diseases and affect 1 in 5,000 children born each year.

"This may become th
'"/>

Contact: Gwen Ericson
ericsong@wustl.edu
314-286-0141
Washington University School of Medicine
9-Jan-2007


Page: 1 2 3

Related biology news :

1. Dramatic shift from simple to complex marine ecosystems occurred 250M years ago at mass extinction
2. Dramatic rise in number of authors publishing in open access journals, independent survey finds
3. Cooperative science program yields results
4. Delayed treatment of childhood-onset bipolar disorder results in negative outcome in adults
5. Smelling for first time results from knowing abnormalities in congenital loss of smell
6. BDSI announces positive phase III clinical trial results
7. Scientists meet to review Envisat results after 5 years of operations
8. Environment and exercise may affect research results, UA study shows
9. Preliminary results of largest scan of autism DNA information
10. Human trial results show excellent safety data, from Geovaxs DNA/MVA AIDS vaccines
11. Rodent sperm work together for better results

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/5/2020)... ... June 04, 2020 , ... Greffex, a pioneering vaccine and ... of Directors. , “Neil understands the need for a global perspective to make an ... of Greffex. Mr. Bush will serve as an independent, director of the company. , ...
(Date:5/28/2020)... ... ... CrucialTrak, a global designer and manufacturer of biometric access control systems, today ... and sell its complete line of biometric readers and access gates . CEG ... . , Brett Mason, CrucialTrak’s Director of Channel Sales for the Americas is ...
(Date:5/28/2020)... and FORT WORTH, Texas (PRWEB) , ... May ... ... stage biopharmaceutical company, announced today that interim results from their 1801 Phase 1/2 ... of Clinical Oncology (ASCO) Annual Meeting which will take place virtually on May ...
Breaking Biology News(10 mins):
(Date:6/11/2020)... ... June 08, 2020 , ... Greffex, a leading genetic engineering ... proprietary clean viral vectors, recently announced a key manufacturing agreement with FUJIFILM Diosynth ... the world’s most successful gene therapy delivery vehicle (vector) with broad applications for ...
(Date:6/2/2020)... ... June 01, 2020 , ... As part of ... change in the world, enterprise security solutions provider bitsIO donated time to help ... from home during self-quarantines and shelter-in-place orders, companies are increasingly concerned about the ...
(Date:5/26/2020)... ... ... Brilliant , the leading smart home control and lighting company, and ... new integration to bring more convenience, simplicity, and security to the smart home industry. ... now be controlled from Brilliant’s in-wall touchscreen control panels and mobile app. , ...
(Date:5/15/2020)... (PRWEB) , ... May 14, ... ... supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks and hMSC ... to enable streamlined and multi-format collection of hMSC-derived extracellular vesicles (EVs). RoosterCollect™-EV-CC ...
Breaking Biology Technology:
Cached News: